Report - Phosphodiesterase 4 inhibitor activates AMPK SIRT6 pathway ......AMPK. We found that despite SIRT1 inhibition, both rolipram and db-cAMP increased phosphor-AMPK levels (Figure 4E).

Please pass captcha verification before submit form